ACNE SOLUTIONS CLEANSING GEL

Manufacturer: CLINIQUE LABORATORIES LLC | Estee Lauder Companies Inc. | The Estee Lauder Inc
Effective date: 2023-08-30
Label type: HUMAN OTC DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-05-31 23:56:26

Label at a glance#

ProductACNE CLEANSING

Active ingredientSALICYLIC ACID

Label structure9 sections

Indications and uses

treats acne clears acne blemishes helps prevent development of new acne blemishes

Dosage and administration

Wet hands and work into a lather Add water to increase lather Massage gently over wet skin, avoiding eye area Rinse Use A.M. and P.M. If bothersome drying or peeling occurs, reduce usage to every other day Follow with Acne Solutions Clarifying Lotion

Storage and handling

Protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

treats acne
clears acne blemishes
helps prevent development of new acne blemishes

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Wet hands and work into a lather
Add water to increase lather
Massage gently over wet skin, avoiding eye area
Rinse
Use A.M. and P.M.
If bothersome drying or peeling occurs, reduce usage to every other day
Follow with Acne Solutions Clarifying Lotion

Inactive ingredients

INACTIVE INGREDIENT SECTION

water\aqua\eau [] glycerin [] sodium laureth sulfate [] sodium chloride [] lauramidopropyl betaine [] butylene glycol [] sucrose [] gentiana lutea (gentian) root extract [] laminaria saccharina extract [] caffeine [] sodium hyaluronate [] acetyl glucosamine [] peg-120 methyl glucose dioleate [] benzophenone-4 [] sodium hydroxide [] tetrasodium edta [] disodium edta [] bht [] phenoxyethanol [] blue 1 (ci 42090) <iln50388>

Other information

STORAGE AND HANDLING SECTION

Protect the product in this container from excessive heat and direct sun

PRINCIPAL DISPLAY PANEL - 125 mL Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel

CLINIQUE

acne solutions

cleansing gel

SALICYLIC ACID

ACNE MEDICATION

ALL SKIN TYPES

4.2 FL.OZ.LIQ./125 ml e

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
777d68c6-a5ab-e06c-d314-677b0b9af0c8	Product name	2	20240508
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49527-045-01	2022-08-04	C162847	48780-1	e4f33bdf-b294-d8a0-e053-dadaa90a6e4e	ACNE SOLUTIONS CLEANSING GEL
49527-045-01	2022-07-29	C162847	48780-1	e4f33bdf-b294-d8a0-e053-dadaa90a6e4e	ACNE SOLUTIONS CLEANSING GEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
49527-045-01	ACNE CLEANSING	125 mL in 1 TUBE	GEL	125		9
49527-045-01	ACNE CLEANSING	1 in 1 CARTON	GEL	1		9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49527-045	ACNE CLEANSING (SALICYLIC ACID) GEL [CLINIQUE LABORATORIES LLC]	9	Current NDC, Legacy NDC, 2 package rows	20231005_7bae5802-cf51-4b41-9d7c-d72f1eb4c4af.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
CAFFEINE	INACTIVE INGREDIENT	3G6A5W338E	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	1
EDETIC ACID	INACTIVE INGREDIENT	9G34HU7RV0	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	1
GENTIANA LUTEA ROOT	INACTIVE INGREDIENT	S72O3284MS	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	1
HYALURONATE SODIUM	INACTIVE INGREDIENT	YSE9PPT4TH	1
LAURAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	23D6XVI233	1
LAURETH-2	INACTIVE INGREDIENT	D4D38LT1L5	1
N-ACETYLGLUCOSAMINE	INACTIVE INGREDIENT	V956696549	1
PEG-120 METHYL GLUCOSE DIOLEATE	INACTIVE INGREDIENT	YM0K64F20V	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
SACCHARINA LATISSIMA	INACTIVE INGREDIENT	68CMP2MB55	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
SODIUM LAURETH-3 SULFATE	INACTIVE INGREDIENT	BPV390UAP0	1
SODIUM SULFATE	INACTIVE INGREDIENT	0YPR65R21J	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1
SULISOBENZONE	INACTIVE INGREDIENT	1W6L629B4K	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

ACNE CLEANSING
SALICYLIC ACID
EDETATE DISODIUM ANHYDROUS
WATER
GLYCERIN
SODIUM LAURETH-3 SULFATE
SODIUM CHLORIDE
LAURAMIDOPROPYL BETAINE
BUTYLENE GLYCOL
SUCROSE
GENTIANA LUTEA ROOT
SACCHARINA LATISSIMA
CAFFEINE
HYALURONATE SODIUM
N-ACETYLGLUCOSAMINE
PEG-120 METHYL GLUCOSE DIOLEATE
SULISOBENZONE
SODIUM HYDROXIDE
EDETIC ACID
EDETATE SODIUM
BUTYLATED HYDROXYTOLUENE
PHENOXYETHANOL
FD&C BLUE NO. 1

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49527-045	49527-045-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
EDETATE DISODIUM ANHYDROUS	8NLQ36F6MM	IACT
WATER	059QF0KO0R	IACT
GLYCERIN	PDC6A3C0OX	IACT
SODIUM LAURETH-3 SULFATE	BPV390UAP0	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
LAURAMIDOPROPYL BETAINE	23D6XVI233	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
SUCROSE	C151H8M554	IACT
GENTIANA LUTEA ROOT	S72O3284MS	IACT
SACCHARINA LATISSIMA	68CMP2MB55	IACT
CAFFEINE	3G6A5W338E	IACT
HYALURONATE SODIUM	YSE9PPT4TH	IACT
N-ACETYLGLUCOSAMINE	V956696549	IACT
PEG-120 METHYL GLUCOSE DIOLEATE	YM0K64F20V	IACT
SULISOBENZONE	1W6L629B4K	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
EDETIC ACID	9G34HU7RV0	IACT
EDETATE SODIUM	MP1J8420LU	IACT
BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
SALICYLIC ACID	O414PZ4LPZ	ACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 146 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOAP / TOPICAL	0.01 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
SODIUM LAURETH-3 SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	CREAM / TOPICAL	NA		Exact identifier — unii+route 6 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
PEG-120 METHYL GLUCOSE DIOLEATE	PEG-120 METHYL GLUCOSE DIOLEATE	YM0K64F20V	SHAMPOO / TOPICAL		300 mg	Exact identifier — unii+route 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SODIUM LAURETH-3 SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	SPRAY / TOPICAL	0.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
EDETIC ACID	EDETIC ACID	9G34HU7RV0	GEL / TOPICAL	0.1 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	CREAM / TOPICAL	0.01 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 96 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SHAMPOO / TOPICAL	0.75 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
PEG-120 METHYL GLUCOSE DIOLEATE	PEG-120 METHYL GLUCOSE DIOLEATE	YM0K64F20V	SHAMPOO / TOPICAL		300 mg	Exact identifier — unii+route 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	GEL / TOPICAL		8 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOAP / TOPICAL	0.01 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
SODIUM SULFATE	SODIUM SULFATE	0YPR65R21J	SHAMPOO / TOPICAL	5 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / TOPICAL	0.01 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
LAURETH-2	LAURETH-2	D4D38LT1L5	SHAMPOO / TOPICAL	2 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
SODIUM SULFATE	SODIUM SULFATE	0YPR65R21J	SOAP / TOPICAL	0.05 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SODIUM LAURETH-3 SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	SHAMPOO / TOPICAL		3192 mg	Exact identifier — unii+route 6 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
LAURETH-2	LAURETH-2	D4D38LT1L5	SHAMPOO / TOPICAL	2 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
CAFFEINE	CAFFEINE	3G6A5W338E	GRANULE / ORAL	NA		Exact identifier — unii candidate 6 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 96 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 96 equally ranked IID candidates
SODIUM LAURETH-3 SULFATE	SODIUM LAURETH-3 SULFATE	BPV390UAP0	CREAM / TOPICAL	NA		Exact identifier — unii+route 6 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ACNE CLEANSING	SALICYLIC ACID	CLINIQUE LABORATORIES LLC	7bae5802-cf51-4b41-9d7c-d72f1eb4c4af	2023-08-30	Warnings	Exact identifier ndc (package): 49527-045-01 ndc (product): 49527-045 ndc11 (package): 49527004501 spl id: 0426793e-20f4-f176-e063-6294a90a601a spl set id: 7bae5802-cf51-4b41-9d7c-d72f1eb4c4af

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.